US 9801873
Methods for treating humans having brain cancer
granted A61KA61K31/4745A61K47/60
Quick answer
US patent 9801873 (Methods for treating humans having brain cancer) held by Nektar Therapeutics expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/4745, A61K47/60, A61P, A61P15/00